Strength training and longevity: muscle is the organ of longevity

Of all the physical attributes that predict longevity, muscle strength is among the most powerful. The PURE study (Leong et al., Lancet, 2015) followed 139,691 adults across 17 countries and found that grip strength was a stronger predictor of cardiovascular mortality than systolic blood pressure. Ruiz et al. (BMJ, 2008) followed 8,762 men for 18.9 years and found that men in the lowest third of muscular strength had a 60% higher all-cause mortality risk than those in the highest third, independent of cardiorespiratory fitness. Muscle is not merely the tissue that moves your body — it is an endocrine organ, a metabolic buffer, and a structural reserve that determines your resilience to the diseases and injuries of aging.

Skeletal muscle as a metabolic organ

Skeletal muscle accounts for approximately 40% of body mass in healthy adults and is the largest site of glucose disposal in the body. After a meal, 70–80% of ingested glucose is taken up by skeletal muscle via GLUT4 transporters. This uptake is driven by both insulin signalling and muscle contraction — meaning that muscle mass and muscle activity are the two primary determinants of postprandial glucose control. People with low muscle mass have chronically elevated postprandial glucose, driving insulin resistance, hyperinsulinaemia, and eventually type 2 diabetes.

Muscle also serves as the body's primary amino acid reservoir. During illness, injury, or prolonged fasting, the body catabolises muscle protein to provide gluconeogenic substrates and immune precursors. People with low muscle mass — sarcopenia — have a depleted reserve to draw on during these catabolic states, which is why sarcopenic individuals have dramatically worse outcomes from hospitalisation, surgery, cancer treatment, and critical illness. This is sometimes called the 'muscle as currency' model: you spend muscle mass during illness, and if you have insufficient reserves, you go bankrupt.

The myokine hypothesis

Skeletal muscle is an endocrine organ that secretes over 600 signalling proteins called myokines during contraction. These myokines mediate many of the systemic benefits of exercise that cannot be explained by cardiovascular or metabolic mechanisms alone.

Key myokines include: Irisin, which is released during exercise and drives the browning of white adipose tissue (converting it to metabolically active beige fat), improves insulin sensitivity, and has neuroprotective effects including increasing BDNF in the hippocampus. IL-6, which when released from muscle during exercise has anti-inflammatory effects (in contrast to IL-6 from adipose tissue, which is pro-inflammatory). BDNF (brain-derived neurotrophic factor), which supports neuronal survival, synaptic plasticity, and hippocampal neurogenesis — the biological substrate of learning and memory. IGF-1, which is produced locally in muscle in response to mechanical loading and drives muscle protein synthesis via the PI3K/Akt/mTOR pathway.

Sarcopenia: the silent epidemic

Sarcopenia — the age-related loss of muscle mass and function — begins in the fourth decade of life and accelerates after 60. Without intervention, adults lose approximately 3–8% of muscle mass per decade after 30, and up to 15% per decade after 70. By age 80, the average person has lost 30–40% of their peak muscle mass. This loss is not merely cosmetic: it is associated with falls, fractures, metabolic disease, immune dysfunction, and dramatically increased mortality.

The mechanisms of sarcopenia are multiple and interacting: (1) Anabolic resistance — older muscle is less responsive to the muscle-building signals of protein and exercise, requiring higher doses of both to achieve the same synthetic response. (2) Motor neuron loss — aging is associated with progressive loss of fast-twitch motor units, reducing power and speed. (3) Mitochondrial dysfunction — aging muscle has fewer and less efficient mitochondria, reducing energy production and increasing oxidative stress. (4) Chronic inflammation — elevated IL-6, TNF-α, and CRP in older adults suppress muscle protein synthesis and accelerate protein breakdown. (5) Hormonal decline — falling testosterone, oestrogen, and IGF-1 reduce anabolic drive.

The grip strength data in detail

Grip strength has emerged as one of the most powerful and practical biomarkers of overall health and longevity. It is easy to measure (requiring only a hand dynamometer), highly reproducible, and reflects whole-body muscle quality rather than just hand strength. The PURE study found that each 5 kg decrease in grip strength was associated with a 16% increase in all-cause mortality, a 17% increase in cardiovascular mortality, and a 9% increase in non-cardiovascular mortality. The effect was consistent across all 17 countries studied, suggesting it reflects a fundamental biological relationship rather than a culturally specific pattern.

Normative grip strength values decline with age. For men aged 40–49, the average grip strength is approximately 46 kg; for men aged 70–79, it is approximately 32 kg. For women, the corresponding values are approximately 27 kg and 19 kg. Being in the lowest quartile for your age and sex is associated with a substantially elevated mortality risk and should prompt aggressive intervention.

Resistance training in older adults: the evidence

Fiatarone et al. (NEJM, 1994) conducted a landmark trial in 100 frail nursing home residents with a mean age of 87. Ten weeks of high-intensity resistance training produced a 113% increase in muscle strength, a 12% increase in gait speed, and a 28% increase in stair-climbing power. This was the first rigorous demonstration that even the oldest and most frail individuals can build meaningful muscle and functional capacity with resistance training. The effect size was larger than any drug intervention studied in this population.

More recent meta-analyses confirm that resistance training produces significant gains in muscle mass, strength, and functional capacity at all ages, including in people over 80. The adaptations are somewhat attenuated in older adults compared to younger adults, but they are clinically meaningful. A 2017 Cochrane review found that progressive resistance training reduced fall risk in older adults by 34% and improved physical function across multiple domains.

Muscle and cancer

Higher muscle mass is associated with lower cancer incidence and better cancer outcomes across multiple cancer types. The mechanisms include: (1) Insulin and IGF-1 signalling — muscle mass improves insulin sensitivity, reducing the chronic hyperinsulinaemia that drives cancer cell proliferation. (2) Immune function — muscle-derived myokines including IL-15 and irisin enhance natural killer cell activity and cytotoxic T cell function. (3) Metabolic competition — muscle tissue competes with tumours for glucose and amino acids. (4) Chemotherapy tolerance — sarcopenic patients have significantly higher rates of chemotherapy toxicity, dose reductions, and treatment discontinuation.

Protein: the non-negotiable

Muscle protein synthesis requires an adequate supply of essential amino acids, particularly leucine, which acts as the primary anabolic trigger via mTORC1 activation. Morton et al. (British Journal of Sports Medicine, 2018) meta-analysed 49 RCTs and found that protein supplementation significantly augmented muscle mass and strength gains from resistance training, with a plateau effect at approximately 1.62 g/kg body weight per day in younger adults. In older adults, the threshold is higher due to anabolic resistance: 2.0–2.2 g/kg per day is recommended.

Protein distribution matters as much as total intake. Muscle protein synthesis is maximally stimulated by a dose of approximately 0.4 g/kg per meal, with diminishing returns above this threshold. Distributing protein intake across 4–5 meals per day therefore produces greater total muscle protein synthesis than consuming the same amount in 1–2 large meals. A protein-rich meal within 2 hours of resistance training (the 'anabolic window') maximises the training-induced stimulus for muscle protein synthesis.

The practical protocol

• Train with resistance 2–3 times per week, targeting all major muscle groups (legs, back, chest, shoulders, arms) in each session or across a split.
• Prioritise compound movements: squats, deadlifts, hip hinges, rows, presses, and pull-ups produce the greatest hormonal and myokine responses.
• Train to within 2–3 repetitions of failure on each set. Proximity to failure, not absolute load, is the primary driver of hypertrophic adaptation.
• Perform 10–20 sets per muscle group per week, distributed across 2–3 sessions. This is the evidence-grounded volume range for hypertrophy.
• Consume 1.6–2.2 g of protein per kg body weight per day, distributed across 4–5 meals. Older adults (50+) should target the upper end of this range.
• Include a protein-rich meal (0.4 g/kg) within 2 hours of training to maximise the anabolic window.
• Measure grip strength annually as a longevity biomarker. A hand dynamometer costs under £20 and provides a reliable benchmark.
• Do not neglect leg training: lower body strength is more strongly associated with longevity than upper body strength in most studies.